We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Details Process for Breakthrough Therapy Designation
FDA Guidance Details Process for Breakthrough Therapy Designation
June 28, 2013
The FDA issued a long-awaited guidance June 25 outlining how pharma companies can receive a breakthrough therapy designation for a new drug, opening a door to faster approval.